What are the red flags for Marc L. Boom, MD?

AHA Dossiers Power Map About

Marc L. Boom, MD

2027 Immediate Past Chair (2026 Chair)

President & CEO | Houston Methodist

Last verified November 4, 2026

7 Red Flags

Affiliations

•2026 AHA Board Chair (Chair-Elect Designate 2024, Chair-Elect 2025), becoming Immediate Past Chair on January 1, 2027. As chair he helped select Steve Walsh to succeed Rick Pollack.
•Has been President & CEO of Houston Methodist since 2012. Houston Methodist is an academic system anchored by its Texas Medical Center flagship, affiliated with Weill Cornell Medicine.
•Sits on the board of directors of the Houston Branch of the Federal Reserve Bank of Dallas, for a three-year term that began in January 2024.
•Past Chair (2021) of the Texas Hospital Association.
•Member of the Vizient CEO Executive Board. Vizient is the nation's largest hospital group purchasing organization.
•Past Chair (2023) of the Greater Houston Partnership; serves on the Houston advisory board of Amegy Bank (Zions Bancorporation).
•Wrote the AHA 'Chair File' column and hosted the Leadership Dialogue series throughout 2026, covering advocacy, rural hospitals, AI and patient safety.

Financial / Compensation

•FY2024 Form 990 for Methodist Hospital Group (filed November 7, 2025): Boom is listed by name with $7,251,200 in reportable compensation and $1,087,378 in other compensation, about $8.34 million in total.
•That is up from about $7.14 million in total compensation on the FY2023 Methodist Hospital Group return.
•Methodist Hospital Group FY2024: revenue of $4.40 billion, expenses of $3.93 billion, an excess of about $470 million, and net assets of $6.91 billion. FY2023 revenue was $3.93 billion with an excess of about $390 million.
•The Methodist Hospital (flagship entity) FY2024: revenue of $3.60 billion, expenses of $3.28 billion, an excess of about $313 million, total assets of $11.86 billion and net assets of $8.46 billion.
•The next-highest-paid executives named on the FY2024 group return were Kevin Burns ($2.93M), Roberta Schwartz, PhD ($2.77M) and Ramon Cantu ($2.47M).
•The Lown Institute lists Houston Methodist Hospital with about $1.15 billion in real estate, property that is largely shielded from local property tax by its nonprofit status.

Lobbying and Political

•Houston Methodist reported $200,000 in federal lobbying in 2024 and $200,000 in 2025, according to OpenSecrets. A 2026 year-to-date figure could not be confirmed.
•Houston Methodist-affiliated individuals and PACs gave $203,937 in the 2024 cycle, according to OpenSecrets.
•Houston Methodist Hospital is a registered lobbying client in Texas, active on Medicaid financing, property-tax exemption, scope of practice and surprise billing.
•As 2026 AHA chair, Boom presided over an association that reported $25.47 million in federal lobbying in 2025 and $14.39 million in the first three quarters of 2026.
•In an October 2026 AHA interview, Boom named 340B, site-neutral payment and mitigating the effects of the 2025 reconciliation law (OBBBA) as AHA's near-term fights.

Revolving Door

•His Federal Reserve Bank of Dallas Houston Branch directorship (from January 2024) gives the CEO of one of Houston's largest employers a seat in the regional monetary-policy apparatus while he chairs the hospital lobby.
•As 2026 AHA chair, he was the hospital industry's top elected officer in dealings with Congress, HHS and CMS during the fight over Medicaid cuts in the 2025 reconciliation law and over 340B rebates.
•He was not among the members HHS/CMS named to its Healthcare Advisory Committee in March 2026; his successor as AHA chair, Bill Gassen, was.

Home System Record

•Houston Methodist Hospital received a D for equity on the Lown Institute Hospitals Index, ranking 3,724 of 3,764 hospitals nationally and 265 of 269 in Texas. Lown's fair-share analysis estimates a deficit of about $222 million, meaning the value of its tax exemption exceeds its spending on community investment.
•Three Houston Methodist hospitals (Willowbrook, Baytown and West) take part in the 340B program. A 2022 FDLI analysis said acquiring outpatient sites let Methodist bill chemotherapy drugs through 340B, 'resulting in $50 million in profits to Methodist in one year alone.'
•In a 2025 comment letter, Houston Methodist told CMS that combined 340B payment reductions 'would severely destabilize hospital operations.'
•Rice University's Baker Institute found that Houston Methodist did not post prices for more than a year after the January 2021 federal transparency deadline, and later found major insurer rates missing from its file. Rice researchers reported continued extreme price variation in 2025.
•Houston Methodist confirmed to KPRC 2 in 2024 that it charges facility fees at hospital-based outpatient clinics (transplant, wound care, radiation oncology, infusion), the practice site-neutral reform targets.
•It has expanded mainly by building in affluent suburbs: the $650M+ Houston Methodist Cypress Hospital opened in March 2025, and a $247M expansion of Houston Methodist West was announced in August 2024.

Litigation and Scrutiny

•Houston Methodist paid $9.99 million to settle DOJ False Claims Act allegations that it inflated charges in 2001-2003 to obtain improper Medicare outlier payments.
•In October 2025, Texas AG Ken Paxton warned Boom that Houston Methodist might be violating HB 4076 by denying organ transplants to unvaccinated patients. The system denied having such a policy. No public enforcement action was found as of November 2026.
•Houston Methodist is one of roughly 450 providers suing major insurers over alleged suppression of out-of-network rates through Claritev (formerly MultiPlan) in the Northern District of Illinois. DOJ filed a statement of interest backing plaintiffs in March 2025, and no trial is expected before 2027.
•Bridges v. Houston Methodist: the suit by employees fired over the 2021 COVID-19 vaccine mandate was dismissed, and the Fifth Circuit affirmed. Fired staff were reported to be seeking Supreme Court review in January 2026, and the outcome could not be confirmed.
•In 2022, ENT physician Mary Bowden sued Houston Methodist for $25 million, alleging defamation after the system publicly criticized her COVID-19 vaccine statements.

Red Flags

The 2026 AHA chair took about $8.34 million in FY2024 pay from a nonprofit system that posted a $470 million surplus on $4.4 billion in revenue.

Lown ranks his flagship 3,724th of 3,764 on equity and estimates a roughly $222 million fair-share deficit. The tax exemption is worth more than what the system returns to the community, even while AHA tells Congress that nonprofits more than earn their exemption.

He reportedly made $50 million in one year from 340B by acquiring outpatient sites, then chaired the association suing to stop 340B rebates that would let manufacturers verify discounts.

Houston Methodist charges hospital facility fees at outpatient clinics while AHA, under his chairmanship, fought site-neutral payment that would end that markup.

His system ignored the federal price transparency rule for more than a year, later posted files missing major payer rates, and the association he chaired had sued to kill the rule.

Federal Reserve branch board seat: a hospital CEO with a seat in the regional monetary-policy apparatus while serving as the hospital lobby's chair.

Capital follows insured patients: hundreds of millions in new suburban capacity in Cypress, West Houston and The Woodlands while the urban flagship lags on community benefit.

Pattern Summary

Marc Boom runs a $4.4 billion nonprofit that posted a $470 million surplus and paid him about $8.34 million in FY2024, while Lown ranks his flagship near last in the country on equity and community benefit. As 2026 AHA chair, he led the fights to protect exactly the revenue streams his own system uses: 340B margins, facility fees and opaque pricing. He hands the gavel to Bill Gassen in January 2027 but stays on the AHA's executive leadership as Immediate Past Chair.

Marc L. Boom, MD

Red Flags

Sources and Citations